Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods For Therapeutic Gene Editing

-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lympho

Related Keywords

United States ,Massachusetts ,Cambridge ,Cambridgeshire ,United Kingdom ,Christopher Rohde ,Wilson Sonsini Goodrich Rosati ,Matt Angel ,Trademark Office ,Factor Bioscience Inc ,Technology Officer ,Bioscience Inc ,United States Patent ,Chief Technology ,Wilson Sonsini Goodrich ,